Skip to content

Insider · CIK 0001298079

Brazzell Romulus K

Reports to the SEC for 2 companies · DURHAM, NC

Transactions

50

Companies

2

Filings

9

CIK

0001298079

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-10-22KALAKALA BIO, Inc.S Sale−$38.8K
2025-06-24KALAKALA BIO, Inc.S Sale−$21.1K
2025-06-03KALAKALA BIO, Inc.S Sale−$13.8K
2025-01-06KALAKALA BIO, Inc.A Award—
2025-01-06KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2025-01-06KALAKALA BIO, Inc.S Sale−$18.7K
2024-06-26KALAKALA BIO, Inc.S Sale−$26.1K
2024-05-31KALAKALA BIO, Inc.S Sale−$12.2K
2024-01-04KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2024-01-04KALAKALA BIO, Inc.S Sale−$10.9K
2024-01-04KALAKALA BIO, Inc.A Award—
2023-06-22KALAKALA BIO, Inc.A Award—
2023-06-22KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc. · Stock Option (right to buy)D Disposition to Issuer—
2023-05-31KALAKALA BIO, Inc.A Award—
2023-03-14KALAKALA BIO, Inc. · Stock Option (Right to Buy)A Award—
2023-01-04KALAKALA BIO, Inc.S Sale−$2,082.69
2023-01-04KALAKALA BIO, Inc.A Award—
2022-10-26KALAKALA BIO, Inc.S Sale−$1,699.11
2022-06-27KALAKALA BIO, Inc.S Sale−$1,163.28
2022-01-04KALAKALA BIO, Inc.S Sale−$4,555.2
2022-01-03KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2021-10-26KALAKALA BIO, Inc.S Sale−$23K
2021-06-28KALAKALA BIO, Inc.S Sale−$17.5K
2021-01-04KALAKALA BIO, Inc.A Award—
2021-01-04KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2020-10-26KALAKALA BIO, Inc.A Award—
2020-06-25KALAKALA BIO, Inc.A Award—
2020-04-09KALAKALA BIO, Inc.M Exercise/Conversion+$42K
2020-04-09KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2020-04-09KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2020-04-09KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion—
2020-04-09KALAKALA BIO, Inc.M Exercise/Conversion+$159K
2020-04-09KALAKALA BIO, Inc.M Exercise/Conversion+$1,278.4
2020-01-02KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2019-01-02KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2018-02-07KALAKALA BIO, Inc. · Stock Option (right to buy)A Award—
2017-08-11KALAKALA BIO, Inc.M Exercise/Conversion+$24.5K
2017-08-11KALAKALA BIO, Inc.M Exercise/Conversion+$11K
2017-08-11KALAKALA BIO, Inc.M Exercise/Conversion+$102K
2017-08-11KALAKALA BIO, Inc.M Exercise/Conversion+$40.6K
2017-08-11KALAKALA BIO, Inc. · Stock Option (right to buy)M Exercise/Conversion—

Recent filings

9

Companies

2

Address

C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200

DURHAM, NC, 27703